US Patent Issued to NovaTarg on July 29 for "Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy" (North Carolina Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,404, issued on July 29, was assigned to NovaTarg Inc. (Research Triangle Park, N.C.).

"Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy" was invented by Kenneth Batchelor (Wilmington, N.C.), Jeffery E. Cobb (Chapel Hill, N.C.), Kristjan S. Gudmundsson (Raleigh, N.C.), Brad R. Henke (Cary, N.C.) and Francis X. Tavares (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides novel fused bicyclic alkylene linked imidodicarbonimidic diamides. In particular, described herein are N-[2-(indol-3-yl)alkylene]-linked imidodicarbonimidic diamides and N-[2-(pyrrolopyridin-...